Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications Health Condition 2: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: Comparison between metformin and non metformin exposed groups: Comparison between metformin and non metformin exposed groups
Sponsors
NITTE (Deemed to be University, NGSM Institute of Pharmaceutical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1.The exposed group includes individuals treated with metformin mono therapy or combination of metformin with other anti-diabetic drugs for minimum two years. 2.The non-exposed group includes individuals treated with other anti-diabetic drugs except for metformin for minimum two years. 3.Patients must be on stable anti-diabetic therapy for minimum 2 years. 4.Age criteria - between 18 to 59 years with stable medical condition in the past year and regular clinical follow up.
Exclusion criteria
Exclusion criteria: 1.Subjects will be excluded if they had Dementia, Parkinson’s disease, severe depression, neurological disorders or could not complete the study procedure. 2.Breast feeding and pregnant women will be excluded. 3.Patients diagnosed with type 1 diabetes will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study will analyse the relationship between frailty and medication adherence in metformin exposed and non-metformin exposed groups.Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| The study will reflect the association between frailty & glycemic control.Timepoint: 6 months | — |
Countries
India
Contacts
Public ContactDr Uday Venkat Mateti
NGSM Institute of Pharmaceutical Sciences
Outcome results
None listed